technology oversight

Amidst rapid AI advancement, lawmakers and industry leaders advocate for structured development and deployment. Senator Blumenthal calls for “objective review” of new AI products, stressing the urgency to prevent loss of control. This aligns with concerns from AI CEOs like Amodei and Altman. While balancing competitiveness, Blumenthal suggests an FDA-like model for expert oversight, warning against repeating social media’s regulatory oversights.